These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9029720)

  • 1. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC
    Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Agarwal AK
    Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
    Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC
    Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype.
    Mune T; White PC
    Hypertension; 1996 Jun; 27(6):1193-9. PubMed ID: 8641723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.
    Stewart PM; Krozowski ZS; Gupta A; Milford DV; Howie AJ; Sheppard MC; Whorwood CB
    Lancet; 1996 Jan; 347(8994):88-91. PubMed ID: 8538347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
    Agarwal AK; Rogerson FM; Mune T; White PC
    J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):473-9. PubMed ID: 8547172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol to cortisone: glucocorticoid to mineralocorticoid.
    Stewart PM; Mason JI
    Steroids; 1995 Jan; 60(1):143-6. PubMed ID: 7792800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
    Nunez BS; Rogerson FM; Mune T; Igarashi Y; Nakagawa Y; Phillipov G; Moudgil A; Travis LB; Palermo M; Shackleton C; White PC
    Hypertension; 1999 Oct; 34(4 Pt 1):638-42. PubMed ID: 10523339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
    Li A; Li KX; Marui S; Krozowski ZS; Batista MC; Whorwood CB; Arnhold IJ; Shackleton CH; Mendonca BB; Stewart PM
    J Hypertens; 1997 Dec; 15(12 Pt 1):1397-402. PubMed ID: 9431844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth.
    Krozowski ZS; Stewart PM; Obeyesekere VR; Li K; Ferrari P
    Clin Exp Hypertens; 1997; 19(5-6):519-29. PubMed ID: 9247735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system.
    Seckl JR; Chapman KE
    Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
    Stewart PM; Murry BA; Mason JI
    J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.
    Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM
    Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.